# A Mouthwash Medicine for the Reduction or Prevention of Mouth Ulceration Caused by Radiotherapy for Head and Neck Cancer

> **NCT06669390** · PHASE1 · COMPLETED · sponsor: **VasoDynamics Ltd** · enrollment: 15 (actual)

## Conditions studied

- Oral Mucositis

## Interventions

- **DRUG:** NG11-2

## Key facts

- **NCT ID:** NCT06669390
- **Lead sponsor:** VasoDynamics Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-05-22
- **Primary completion:** 2024-08-20
- **Final completion:** 2024-08-20
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2024-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06669390

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06669390, "A Mouthwash Medicine for the Reduction or Prevention of Mouth Ulceration Caused by Radiotherapy for Head and Neck Cancer". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT06669390. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*